Glancing behind virus load variation in HIV-1 infection.
暂无分享,去创建一个
Sebastian Bonhoeffer | Huldrych F Günthard | Marek Fischer | H. Günthard | M. Fischer | S. Bonhoeffer | V. Müller | G. A. Funk | Viktor Müller | Georg A Funk
[1] V. Calvez,et al. HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. , 1999, AIDS.
[2] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[3] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[4] P. Vernazza,et al. Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study. , 2000 .
[5] C. Yoder,et al. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression , 2000, AIDS.
[6] Athanasius F. M. Marée,et al. Small variations in multiple parameters account for wide variations in HIV–1 set–points: a novel modelling approach , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[7] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[8] A. Trkola,et al. Residual Cell-Associated Unspliced HIV-1 Rna in Peripheral Blood of Patients on Potent Antiretroviral Therapy Represents Intracellular Transcripts , 2001, Antiviral therapy.
[9] M. Lederman,et al. Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points. , 1999, The Journal of infectious diseases.
[10] H. Günthard,et al. Human Immunodeficiency Virus-Specific CD8+ T-Cell Responses Do Not Predict Viral Growth and Clearance Rates during Structured Intermittent Antiretroviral Therapy , 2002, Journal of Virology.
[11] A S Perelson,et al. Improved estimates for HIV-1 clearance rate and intracellular delay. , 1999, AIDS.
[12] Beda Joos,et al. Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells. , 2001 .
[13] John E. Mittler,et al. Viral dynamics in primary HIV-1 infection , 2000 .
[14] A. Perelson,et al. Influence of delayed viral production on viral dynamics in HIV-1 infected patients. , 1998, Mathematical biosciences.
[15] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[16] J. Montaner,et al. Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection. , 1996, The Journal of infectious diseases.
[17] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[18] M. Schambelan,et al. Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. , 1997, The Journal of infectious diseases.
[19] M A Nowak,et al. Competition between zidovudine‐sensitive and zidovudine‐resistant strains of HIV , 1992, AIDS.
[20] A S Perelson,et al. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.
[21] L M Wahl,et al. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[22] A S Perelson,et al. Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.
[23] C. Sabin,et al. Course of viral load throughout HIV-1 infection. , 2000 .
[24] A. Telenti,et al. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. , 2003, Archives of internal medicine.
[25] M A Nowak,et al. Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] A S Perelson,et al. Target cell limited and immune control models of HIV infection: a comparison. , 1998, Journal of theoretical biology.
[27] T. Elbeik,et al. Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.
[28] J J Goedert,et al. Longitudinal HIV-1 RNA levels in a cohort of homosexual men. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[29] A S Perelson,et al. Rate of HIV‐1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen , 1998, AIDS.
[30] R. Weber,et al. Effects of Early Antiretroviral Treatment on HIV‐1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy , 2000, Journal of acquired immune deficiency syndromes.
[31] Alan S. Perelson,et al. Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen , 1998, The Journal of experimental medicine.
[32] M A Nowak,et al. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[34] Alan S. Perelson,et al. Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy , 2001, The Journal of experimental medicine.
[35] Martin A. Nowak,et al. Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA , 1999, The Journal of experimental medicine.
[36] Z. Grossman,et al. Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] Alan S. Perelson,et al. A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo , 2003, Journal of Virology.
[38] C H Fox,et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.
[39] Douglas D. Richman,et al. Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.
[40] Sebastian Bonhoeffer,et al. HIV results in the frame , 1995, Nature.